Q-Line Biotech Shareholding Pattern & Promoter Holding
· Latest pattern: Sep 2026
As of Sep 2026, promoters hold 67.51% of Q-Line Biotech, FIIs hold 0.88%, DIIs hold 8.15% and the public holds 23.45%. Promoter holding was unchanged from May 2026.
Get an alert when Q-Line Biotech reports results or its shareholding changes. Free account.
Promoters
67.51%
unchanged QoQ
FIIs
0.88%
−0.79 pp QoQ
DIIs
8.15%
−1.99 pp QoQ
Public
23.45%
+2.78 pp QoQ
Q-Line Biotech shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 67.51% | 0.88% | 8.15% | 23.45% | 2,948 |
| May 2026 | 67.51% | 1.67% | 10.14% | 20.67% | 3,497 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹1.14k cr, the promoter group's 67.51% stake is worth ₹769 cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in peers
Q-Line Biotech shareholding: common questions
What is the promoter holding in Q-Line Biotech?
Promoters hold 67.51% of Q-Line Biotech as of Sep 2026. Their stake was unchanged from May 2026.
How much do FIIs hold in Q-Line Biotech?
Foreign institutional investors (FIIs) held 0.88% of Q-Line Biotech in Sep 2026, −0.79 pp versus May 2026.
How much do mutual funds and other DIIs hold in Q-Line Biotech?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 8.15% of Q-Line Biotech in Sep 2026, −1.99 pp versus May 2026.
Is the promoter holding in Q-Line Biotech pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Q-Line Biotech.
How many shareholders does Q-Line Biotech have?
Q-Line Biotech had 2,948 shareholders in Sep 2026, compared with 3,497 in May 2026.